" class="no-js "lang="en-US"> CytoReason - Medtech Alert
Thursday, October 03, 2024
CytoReason | Pharmtech Focus

CytoReason

About CytoReason

CytoReason

CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies can identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of drug approval. To date, five of the world’s top ten pharma companies use CytoReason’s technology.

Related Story

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development

September 21 2022

CytoReason today announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence […]